Skip to content

Morphological Detection of Liquid-based Thin-layer Film-making Fungi for Fungal Vaginitis in Multiple Hospitals

A Multicenter Clinical Study on Liquid-based Morphological Detection of Fungi

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04984460
Enrollment
1000
Registered
2021-07-30
Start date
2021-07-09
Completion date
2023-04-01
Last updated
2021-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaginitis

Keywords

Fluorescence morphological, liquid-based thin-layer film-making, Fungal vaginitis

Brief summary

The purpose of this study is to compare the results of different detection methods for non-gestational fungal vaginitis (VVC), and to evaluate the significance of different fungal states in the results for diagnosis and treatment.

Detailed description

The study was divided into two phases: in the first phase, the vaginal secretions of 1000 enrolled patients with fungal vaginitis were detected with 3/4 different methods, and the sensitivity, specificity and consistency of these methods were compared; In the second stage, 1000 patients from the first stage were selected to meet the follow-up stage and divided into two groups. The test of Follow-up fungal culture and fluorescence morphological detection of liquid-based thin-layer film-making fungi were performed periodically. At last, the applicant will analyze the data, write the paper and publish the article.

Interventions

DIAGNOSTIC_TESTFluorescence morphological detection of liquid-based thin-layer film-making fungi

Samples from outpatient or inpatient clinics to be tested for fungal vaginitis. A sample of one or more of the following characteristics. Symptoms: vulva pruritus, burning pain, but also accompanied by pain in urine and sexual pain and other symptoms; Leucorrhea increased. Physical signs: Vulva flushing, edema, visible scratches or chaps, white membrane attached to the inner side of the labia minora and the vaginal mucosa, more white bean residue like secretions can be seen in the vagina, which can be curd. Samples are human vaginal secretions. Each sample should be the amount on one swab. The sample is not in menstrual period. The sample subjects did not have vaginal irrigation, medication or sexual intercourse within 3 days.

Sponsors

Affiliated Hospital of Nantong University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
14 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* 1\. Samples from outpatient or inpatient clinics to be tested for fungal vaginitis. * 2\. A sample of one or more of the following characteristics. 2.1 Symptoms: vulva pruritus, burning pain, but also accompanied by pain in urine and sexual pain and other symptoms; Leucorrhea increased. 2.2 Physical signs: Vulva flushing, edema, visible scratches or chaps, white membrane attached to the inner side of the labia minora and the vaginal mucosa, more white bean residue like secretions can be seen in the vagina, which can be curd. * 3\. The samples are vaginal secretions from the female body. Each sample should be the amount on one swab. * 4\. The sample is not in menstrual period. * 5\. The sample subjects did not have vaginal irrigation, medication or sexual intercourse within 3 days.

Exclusion criteria

* 1\. Cases with incomplete specimen collection; * 2\. Mixed vaginitis cases; * 3\. Abscission cases with incomplete follow-up.

Design outcomes

Primary

MeasureTime frameDescription
Comparing the positive detection rate of 3/4 different detection methods in the first phase.From Aug. 1st to Dec. 31st, 2021The positive coincidence rate (sensitivity), negative coincidence rate (specificity) and total coincidence rate (consistency) was compared, according to the P\<0.05 was used to determine whether it was statistically significant.
Calculating the proportion of the number of fungi in three different states in the map results of three/four detection methods.From Aug. 1st, 2021 to Jan. 31st, 2022Counting The number and proportion of mycelia, spores and blastospores, especially the percentage of cases of single spore (+) in all cases of fungus (+).
Counting the positive numbers of 4 or 6 liquid-based thin-layer fungal fluorescence morphological tests and fungal culture in the Stage 2_follow-up stage.From Mar. 1, 2022 to Dec. 31st, 2022the positive coincidence rate (sensitivity), negative coincidence rate (specificity) of 4 or 6 liquid-based thin-layer fungal fluorescence morphological tests

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026